U.S. Food and Drug Administration Approves Gilenya to Treat Relapsing Multiple Sclerosis (MS) in Pediatric Patients Published on May 15, 2018 in CHOP News CHOP co-principal investigator heralds first-ever FDA approval of an MS drug for kids as a major step forward.
In Huntington’s Disease, Heart Problems Shed Light on Disease Process Published on Apr 24, 2018 in CHOP News Abnormal proteins in the brain disorder Huntington’s disease also attack the heart. CHOP researchers improved heart function in animals, a finding relevant to future treatments.
Washington Post Highlights Alexander Disease Research Efforts Published on Apr 23, 2018 in CHOP News Amy Waldman, MD, and a patient family talk about research and fundraising efforts underway that seek to identify better treatment options for Alexander disease.
Children's Hospital of Philadelphia and the United Arab Emirates Sign Medical Services Agreement Published on Apr 16, 2018 in CHOP News CHOP and the United Arab Emirates entered into a Medical Services Agreement to provide expert medical care for children in the UAE, formally documenting their long-standing alliance.
CHOP Researchers Stimulated a Brain Circuit, Leading to “Antidepressive” Behavior in Animals Published on Apr 16, 2018 in CHOP News CHOP researchers discovered a method to stimulate a brain circuit in animals that could someday help treat depression in people.
In a Severe Childhood Neurodegeneration, Novel Mechanism Found Published on Mar 22, 2018 in CHOP News Neurology researchers studying a rare, devastating condition in infants have discovered the cause: gene mutations that disrupt mitochondria in cells.
“Missing Mutation” Found in Severe Infant Epilepsy Published on Mar 20, 2018 in CHOP News CHOP has found a long-suspected “missing mutation” in severe infant epilepsy, with early hints that anti-seizure drugs might help patients.
Biomarkers, Clues to Possible Therapy Found in Novel Childhood Neurogenetic Disease Published on Feb 23, 2018 in CHOP News In a rare genetic disorder causing severe, progressive neurological problems, CHOP researchers find hints that an amino acid supplement might be a targeted therapy.
Advancing Understanding and Care of Leukodystrophies Published on Feb 20, 2018 in Neurosciences Update The Leukodystrophy Center sees patients from all over the country and the world. Our services include a newborn diagnostic clinic and a comprehensive care clinic that provides state-of-the art care.
Innovative Neuroimmune Center Provides Care across the Lifespan Published on Feb 20, 2018 in Neurosciences Update The Pediatric MS and Neuroimmune Clinic at CHOP provides treatment to children with neuroimmune conditions through coordinated care across many specialties.